Nordex Aktie 2083267 / DE000A0D6554
| Kurse + Charts + Realtime | News + Analysen | Fundamental | Unternehmen | zugeh. Wertpapiere | Aktion | |
|---|---|---|---|---|---|---|
| Kurs + Chart | Chart (gross) | News + Adhoc | Bilanz/GuV | Termine | Strukturierte Produkte | Portfolio |
| Times + Sales | Chartvergleich | Analysen | Schätzungen | Profil | Trading-Depot | Watchlist |
| Börsenplätze | Realtime Push | Kursziele | Dividende/GV | |||
| Orderbuch | Analysen | |||||
| Historisch | ||||||
|
04.11.2025 07:00:03
|
EQS-News: Nordex Group delivers strong 3Q/2025 performance with significant margin expansion and robust free cash flow
|
EQS-News: Nordex SE
/ Key word(s): 9 Month figures
Hamburg, 04 November 2025. The Nordex Group (ISIN: DE000A0D6554) reported a strong business performance for the third quarter of 2025. Sales reached around EUR 1.7 billion in 3Q/2025, in line with the previous year quarter (3Q/2024: EUR 1.7 billion). Earnings before interest, taxes, depreciation, and amortization (EBITDA) for the third quarter of 2025 substantially increased by 90.1 percent to EUR 135.9 million (3Q/2024: EUR 71.5 million) with an improved EBITDA margin of 8.0 percent (3Q/2024: 4.3 percent). Net income increased significantly to EUR 51.7 million at the end of 3Q/2025 compared to EUR 3.9 million in the previous year quarter. "Our profitability reached a new level in Q3/2025, driven by strong execution in both our project and service businesses. The significant free cash flow generation highlights our operational strength and disciplined working capital management. With solid order intake and improved visibility, we are confident in sustaining this trajectory and delivering on our upgraded full-year guidance,” explains José Luis Blanco, Chief Executive Officer (CEO) of the Nordex Group. Operational performance In Q3/2025, the Nordex Group recorded 2,170 MW of order intake in the Projects segment, a 25.7 percent increase compared to Q3/2024 (1,726 MW). The total value of new orders rose to EUR 2.0 billion (Q3/2024: EUR 1.6 billion), spanning 16 countries and various turbine variants. The average selling price (ASP) remained stable at EUR 0.93 million/MW (Q3/2024: EUR 0.92 million/MW. As of 30 September 2025, the order book stood at EUR 14.9 billion (September 2024: EUR 11.5 billion), comprising EUR 9.3 billion in the Projects segment (September 2024: EUR 6.9 billion) and EUR 5.6 billion in the Service segment (September 2024: EUR 4.6 billion). Production figures In Q3/2025, Nordex produced 2,541 MW of turbines, a 22.9 percent increase versus Q3/2024 (2,067 MW). Rotor blade output declined by 24.7 percent to 1,122 units (3Q/2024: 1,490 units), due to temporary delays at a supplier factory in Türkiye. Of these, 366 rotor blades units were produced in-house (3Q/2024: 420 units), and 756 units (3Q/2024: 1,070 units) were externally sourced. The Group installed 420 wind turbines across 20 countries, totalling 2,576 MW in the third quarter of 2025, compared to 352 wind turbines in 21 countries with 2,010 MW in 3Q/2024. Of the installed capacity 82 percent was in Europe, 10 percent in “Rest of the World”, 6 percent in North America and 2 percent in Latin America. Segment reporting Sales in the Projects segment were at around EUR 1.5 billion in the third quarter of the year, in line with the prior year (3Q/2024: EUR 1.5 billion), reflecting seasonal dynamics and temporary supplier related delays in Türkiye. The sales in Service segment grew by 9.2 percent to EUR 219.2 million (3Q/2024: EUR 200.7 million). Financial position As of the end of September 2025, total assets remained stable at approximately EUR 5.9 billion, consistent with year-end 2024. The equity ratio improved to 18.3 percent (31 December 2024; 17.7 percent). Cash and cash equivalents rose to EUR 1,378.1 million (31 December 2024: EUR 1,151.4 million), resulting in net cash position of EUR 1,073.0 million (31 December 2024: EUR 848.2 million). The working capital ratio stood at minus 8.2 percent (31 December 2024: minus 9.1 percent). In 3Q/2025, the Nordex Group generated positive free cash flow of EUR 149.0 million (3Q/2024: EUR 159.2 million), driven primarily by solid operational performance. Nordex Guidance for 2025 Following a review of preliminary Q3/2025 results and an updated full-year forecast, Nordex has revised its EBITDA margin guidance upward to 7.5–8.5% (previously: 5.0–7.0%). The improved outlook reflects strong operational execution in both the projects and service segments, supported by a stable macroeconomic environment. All other financial parameters of the guidance remain unchanged. Reporting information The quarterly statement for the nine months of 2025 is now available on the Nordex Group's website in the Investor Relations section under "Publications" (ir.nordex-online.com). The quarterly statement and the condensed consolidated interim financial statements were neither audited nor reviewed by an auditor. Nordex Group key financials
About the Nordex Group The Group has installed around 57 GW of wind power capacity in over 40 markets in its corporate history and generated consolidated sales of around EUR 7.3 billion in 2024. The Company currently has more than 10,400 employees with a manufacturing network that includes factories in Germany, Spain, Brazil, India and USA. Its product portfolio is focused on onshore turbines in the 4 to 7 MW+ classes which are designed to meet the market requirements of countries with limited available space and regions with constrained grid capacity. Contact for press inquiries: Nordex SE Felix Losada Phone: 040 / 300 30 – 1141 flosada@nordex-online.com
Anja Siehler Phone: +49 162 3515 334 asiehler@nordex-online.com
Tobias Vossberg Phone: +49 173 457 3633 tvossberg@nordex-online.com
Rafaela Gunzburger Phone: +49 152 041 43 62 rgunzburger@nordex-online.com
04.11.2025 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group. |
| Language: | English |
| Company: | Nordex SE |
| Erich-Schlesinger-Strasse 50 | |
| 18059 Rostock | |
| Germany | |
| Phone: | +49 381 6663 3300 |
| Fax: | +49 381 6663 3339 |
| E-mail: | investor-relations@nordex-online.com |
| Internet: | www.nordex-online.com |
| ISIN: | DE000A0D6554 |
| WKN: | A0D655 |
| Indices: | MDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Hanover, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 2223026 |
| End of News | EQS News Service |
|
|
2223026 04.11.2025 CET/CEST
Nachrichten zu Nordex AG
|
10.11.25 |
Börse Frankfurt: TecDAX am Mittag mit Gewinnen (finanzen.ch) | |
|
07.11.25 |
EQS-PVR: Nordex SE: Release according to Article 40, Section 1 of the WpHG [the German Securities Trading Act] with the objective of Europe-wide distribution (EQS Group) | |
|
07.11.25 |
Schwacher Wochentag in Frankfurt: TecDAX schwächelt mittags (finanzen.ch) | |
|
07.11.25 |
Starker Wochentag in Frankfurt: TecDAX zum Start des Freitagshandels mit Gewinnen (finanzen.ch) | |
|
06.11.25 |
Anleger in Frankfurt halten sich zurück: TecDAX verbucht schlussendlich Verluste (finanzen.ch) | |
|
06.11.25 |
Börse Frankfurt in Rot: MDAX schlussendlich leichter (finanzen.ch) | |
|
06.11.25 |
Schwacher Wochentag in Frankfurt: MDAX nachmittags mit Abgaben (finanzen.ch) | |
|
06.11.25 |
Zurückhaltung in Frankfurt: TecDAX präsentiert sich am Nachmittag leichter (finanzen.ch) |
Analysen zu Nordex AG
| 06.11.25 | Nordex Buy | Jefferies & Company Inc. | |
| 05.11.25 | Nordex Equal Weight | Barclays Capital | |
| 05.11.25 | Nordex Buy | Goldman Sachs Group Inc. | |
| 05.11.25 | Nordex Buy | Deutsche Bank AG | |
| 04.11.25 | Nordex Underperform | RBC Capital Markets |
Mittwoch um 18 Uhr live: Die Illusion der Erinnerung - Wie du Denkfehler im Trading vermeidest
Erfahrung ist wertvoll - doch Erinnerungen sind trügerisch. Sie verzerren, ergänzen oder lassen Details weg, bis ein falsches Bild entsteht. Dieses Webinar zeigt, warum das Gehirn keine objektive Aufzeichnung liefert und wie diese Verzerrungen Trading-Entscheidungen unbewusst beeinflussen.
Schnell noch Plätze sichern!Abnehmspritzen – Ist der Hype vorbei? – mit Tim Schäfer
Ist der Hype um Abnehmspritzen wie bei Novo Nordisk und Eli Lilly vorbei – oder stehen wir erst am Anfang einer langfristigen Revolution im Gesundheitswesen? 💉📉
Im heutigen Gespräch mit Tim Schäfer @TimSchaeferMedia sprechen wir über die spannendsten Pharmawerte 2025. Neben den Abnehmspritzen blicken wir auch auf klassische Pharma-Giganten wie Pfizer, Johnson & Johnson, Roche, Novartis, AstraZeneca und GSK. Tim analysiert Übertreibungen, Rücksetzer und langfristige Chancen für Buy-and-Hold-Strategien – mit Fokus auf Dividende, KGV und Krisenresistenz.
💬 Was ist vom Abnehmtrend langfristig zu halten?
💬 Welche Pharma-Aktien sind aktuell unterbewertet?
💬 Was spricht für konservative Dividendenwerte im Gesundheitssektor?
👉🏽 https://bxplus.ch/wall-street-live-mit-tim-schaefer/
Inside Trading & Investment
Mini-Futures auf SMI
Inside Fonds
Meistgelesene Nachrichten
Top-Rankings
Börse aktuell - Live Ticker
Shutdown-Ende in Sicht? SMI und DAX schlussendlich stärker -- US-Börsen schliessen mit Gewinnen -- Asiens Börsen letztlich in GrünDer heimische Aktienmarkt präsentierte sich am Montag mit Gewinnen. Anleger am deutschen Aktienmarkt wurden ebenso wieder mutiger. Die Wall Street begann die Woche fester. An den Märkten in Fernost ging es zum Wochenstart nach oben.


